Get the Stockscreener App
2.57
2.28%
-0.06
After Hours:
2.75
0.18
+7.00%
Intelligent Bio Solutions Inc stock is traded at $2.57, with a volume of 123.15K.
It is down -2.28% in the last 24 hours and down -6.88% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
See More
Previous Close:
$2.63
Open:
$2.63
24h Volume:
123.15K
Relative Volume:
0.92
Market Cap:
$6.15M
Revenue:
$3.58M
Net Income/Loss:
$-11.33M
P/E Ratio:
-0.2344
EPS:
-10.9665
Net Cash Flow:
$-9.75M
1W Performance:
-35.91%
1M Performance:
-6.88%
6M Performance:
-62.03%
1Y Performance:
-80.08%
1-Day Range:
$2.53
$2.8099
1-Week Range:
$2.53
$4.143
52-Week Range:
$2.27
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
2.57 | 6.29M | 3.58M | -11.33M | -9.75M | -10.97 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
INBS Q1 2025 Earnings: EPS Misses Estimates as Company Reports No RevenueExpert Trade Signals - Newser
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider Loss Than Expected Weighs on SharesInstitutional Grade Picks - Newser
Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider-Than-Expected Loss Amid Continued Pre-Revenue StageTrending Entry Points - Newser
INBS|Intelligent Bio Solutions Inc|Price:2.530|Chg%:-0.10 - tradingkey.com
Intelligent Bio Solutions Company Profile & Introduction - Moomoo
Intelligent Bio Solutions 3Q Loss $2.87M >INBS - Moomoo
INBS - Finviz
[SCHEDULE 13G] INTELLIGENT BIO SOLUTIONS INC. Passive Investment Disclosure (>5%) - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Intelligent Bio Solutions (INBS) Undervalued After Q3 FY2026 - GuruFocus
Intelligent Bio Solutions (NASDAQ: INBS) grows Q3 revenue 46% with margins above 50% - Stock Titan
Intelligent Bio Reports Q3 Revenue Up 46%, Gross Margin Over 50% as Cartridge Sales Surge - TradingView
Intelligent Bio Solutions 3Q Loss/Shr $1.80 >INBS - Moomoo
Intelligent Bio Solutions Releases Q3 2026 Financial Results - AlphaStreet
Intelligent Bio Solutions Inc. Q3 2026 10-Q Filing: Financial Statements, Reverse Stock Split, and Company Overview - Minichart
Intelligent Bio Solutions Reports 46% Revenue Growth in Q3 FY202 - GuruFocus
Finger-scan drug test maker tops 50% margins as sales jump 46% - Stock Titan
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50% - TradingView
INTELLIGENT BIO SOLUTIONS INC. 3Q 2026: Revenue $1.06M, Net loss $(2.86M) — 10-Q Summary - TradingView
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year - marketscreener.com
Intelligent Bio Solutions (NASDAQ: INBS) boosts revenue but warns on going concern - Stock Titan
Intelligent Bio Solutions Inc. Reports Unaudited Impairment of Long-Lived Assets for the Third Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - tradingkey.com
INBS Q3'26 Earnings: EPS estimate is 1.40 USD - TradingView
INBS Stock Price, Quote & Chart | INTELLIGENT BIO SOLUTIONS IN (NASDAQ:INBS) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Intelligent Bio Solutions Inc (STU:12Q0) Stock Price & 30 Year Financial Data - GuruFocus
How Intelligent (INBS) is reshaping its industry (Trend Weakens) 2026-05-08Gap Down Stocks - newser.com
The moat Intelligent (INBS) is building for long term dominance (Breakdown Watch) 2026-05-05Top Breakouts - newser.com
Intelligent Bio Solutions expects 16% year over year growth in fourth quarter revenue - MSN
Is Intelligent (INBS) stock near resistance (-4.79%) 2026-04-22Verified Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai
Intelligent Bio Solutions Updates Investor Presentation and Share Count - The Globe and Mail
Intelligent Bio : Investor DeckApril 2026 - marketscreener.com
Intelligent Bio Solutions (INBS) Launches Study to Enhance Drug Screening Speed - GuruFocus
Intelligent Bio Solutions Inc. Launches Validation Study to Achieve Sub-3-Minute Results in Roadside Drug Testing Technology - Quiver Quantitative
Fingerprint drug test aims for under-3-minute roadside results - Stock Titan
Intelligent Bio Solutions (NASDAQ: INBS) posts new investor deck and share update - Stock Titan
Is Intelligent (INBS) stock undervalued compared to peers (Extends Gains) 2026-04-20Theta Decay - Cổng thông tin điện tử tỉnh Lào Cai
INBS completes penetration testing for FDA 510(k) submission By Investing.com - Investing.com India
Intelligent Bio Solutions (INBS) Enhances Security Ahead of FDA Submission - GuruFocus
Intelligent Bio Solutions Inc. Advances Fda 510(K) Submission And Completes Penetration Testing - marketscreener.com
INBS completes penetration testing for FDA 510(k) submission - Investing.com
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified - The Manila Times
No major security flaws found as Intelligent Bio readies FDA filing - Stock Titan
Is Intelligent (INBS) Stock Slowing Down | Price at $2.56, Up 4.07%Market Timing - Newser
How cyclical is Intelligent Bio Solutions Incs revenue stream2026 Price Swings & Smart Money Movement Tracker - baoquankhu1.vn
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):